AB-1002 is being studied for the treatment of adults with non-ischemic cardiomyopathy and New York Heart Association (NYHA) Class III heart failure symptoms
Bayer showcased the latest advancements in the transformation of its Pharma business to fuel long-term, sustainable growth as part of its Pharma strategy at its annual Pharma Media Day 2024. We have made significant progress in growing our pipeline
Bangkok Post - Bayer Accelerates Medical Breakthroughs and Growth bangkokpost.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from bangkokpost.com Daily Mail and Mail on Sunday newspapers.
CRISPR Therapeutics Proposes New Appointment to the Board of Directors tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.